A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab
NCT01502423
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
Adalimumab
Sponsor
AbbVie (prior sponsor, Abbott)